Packaging & Labeling CDMOs

Central Pharma Contract Packing Ltd

Ireland

Central Pharma Contract Packing Ltd is an Irish pharmaceutical contract packing company established in 2006, operating multiple sites across different countries. The company provides filling, packing, serialization, specialist storage and logistics, and regulatory support services for pharmaceutical, veterinary, medical device, cell and gene therapy, and healthcare products. Central Pharma has extensive FDA registration for labeling and packing operations across 9 FEI numbers.

CordenPharma is a full-service CDMO providing integrated development and manufacturing of APIs, drug products, and lipid excipients across a global network of cGMP facilities in Europe and North America. The company offers capabilities spanning peptides, oligonucleotides, highly potent and oncology compounds, small molecules, injectables, lipid nanoparticles (LNPs), and oral solid dosage forms. CordenPharma is investing over EUR 500M in a new peptide manufacturing facility in Muttenz, Switzerland, and expanding its Colorado site for large-scale peptide production.

Corealis Pharma Inc. is the same entity as Corealis Pharma, a privately held GMP-compliant CDMO based in Laval, Quebec, Canada. The company specializes in oral solid dosage forms, providing formulation development and cGMP clinical supply manufacturing for Phase I through early Phase III trials. Corealis has expanded its facilities in Laval's Biotech City with an investment of over $10 million and partners with Rottendorf Pharma and Bora Pharmaceuticals for integrated development-to-commercial services.

Dishman Carbogen Amcis Ltd

China

Dishman Carbogen Amcis Ltd is a global CDMO and pharmaceutical outsourcing partner with operations across India, Switzerland, UK, France, Netherlands, and China. With 30 years of experience, they offer custom API development and manufacturing up to 100 metric ton scale, drug product capabilities including highly potent compounds and ADCs, plus finished dosage forms including soft gel capsules and encapsulation. They have received successful USFDA, PMDA, and EDQM inspections.

Domixtar Pharmaceuticals SpA

Italy

Domixtar Pharmaceuticals (DMX Pharma) is Italy's largest CDMO, formed from the merger of Doppel Farmaceutici and Mipharm, and part of the group that includes Alfa Omega for nutraceuticals. With 1,000 professionals serving 105 partners across 30 countries, they offer full-service outsourcing from formulation development through post-marketing, including production, packaging, R&D, logistics, and quality control for pharmaceutical products.

Douglas CDMO

United Kingdom

Douglas CDMO is a division of Douglas Healthcare, an established pharmaceutical company headquartered in New Zealand with a world-class reputation for high standards. The company offers integrated contract development and manufacturing services specializing in high-potency softgels for pharma, biotech, and life science firms.

DPT Laboratories, LTD.

United States

DPT Laboratories, Ltd., a Mylan company with over 80 years of experience, is a leading CDMO specializing in semi-solid and liquid dosage forms including creams, gels, ointments, lotions, solutions, suspensions, emulsions, and aerosol formulations. The company provides integrated services from pre-formulation through commercial-scale cGMP manufacturing and packaging.

Ensera

United States

Ensera (formerly SteriPack) is a global healthcare CDMO specializing in medical device design, contract manufacturing, and pharmaceutical packaging services. The company provides final assembly, kitting, secondary packing of combination products, cleanroom contract manufacturing, and sterile barrier system packing from FDA-registered facilities across Europe, North America, and Asia.

Eromol UK Ltd (Eramol)

United Kingdom

Eramol (formerly Eromol UK Ltd) is a UK-based CDMO specializing in bespoke clinical trial manufacturing services, founded by two Qualified Persons. The company provides end-to-end services including formulation development, primary manufacturing, clinical packaging, QP release, and global distribution from MHRA and HPRA-approved facilities, with a new sterile injectable site opening in early 2026.

Eskag Global Division (Eskag Pharma)

India

Eskag Pharma is an Indian pharmaceutical manufacturer offering third-party and contract manufacturing services for pharmaceuticals, nutraceuticals, and liposomal products. Founded in 1977, the company has 47+ years of experience and markets 39+ products across 50+ cities with 183 formulations and 50+ DGGI-approved molecules.

Eurofins Biopharma Services (CDMO)

Australia

Eurofins Biopharma Services CDMO is a division of Eurofins Scientific offering integrated API and drug product outsourcing services across small molecules and biologics. The company provides services from early-stage development through commercial manufacturing including highly potent drug development, sterile manufacturing/fill-finish, lyophilization, and biologics development through its Alphora brand.

European Medical Contract Manufacturing (EMCM)

Netherlands

European Medical Contract Manufacturing (EMCM) is a Dutch full-service contract manufacturer and centre of excellence in developing and manufacturing sterile medicinal products for the pharmaceutical and medical device markets. The company has 2000m2 of GMP-accredited facilities with cleanrooms from class D to class A, handling liquids, suspensions, gels, and powders in ampoules, vials, pre-filled syringes, and pouches.

EUROPHARTECH

France

EUROPHARTECH (Domes Pharma Manufacturing) is a French GMP-certified CMO (Contract Manufacturing Organisation) specializing in the production of small and medium batch pharmaceutical and veterinary products. The company offers oral solid dosage forms (tablets, capsules, powders) and non-sterile liquids for both human and veterinary markets, with a 500m2 QC laboratory equipped with HPLC, UV-visible, IR, and Karl Fischer analyzers.

Euticals (now part of Curia)

France

Euticals, now part of Curia Global, is a global CDMO with over 30 years of experience in drug discovery, development, and manufacturing across small molecules, generic APIs, sterile drug products, and biologics. Curia (which acquired Euticals through AMRI) operates an extensive global network with hundreds of FDA-registered facilities and provides end-to-end services from API manufacturing through sterile fill/finish.

Evonik Industries AG

Canada

Evonik Industries AG is a global specialty chemicals company that operates as a leading CDMO for complex parenteral drug products, focusing on polymeric and lipid-based delivery systems including liposomes, nanoparticles, microparticles, implants, and LNP formulations. The company's Health Care division provides end-to-end CDMO services for small molecules, peptides, nucleic acids (mRNA, siRNA), and HPAPIs, with FDA-inspected facilities in the US and Canada and 34 FDA inspections with zero OAI outcomes.

FAMAR

Greece

FAMAR is a leading European pharmaceutical CDMO headquartered in Greece with a network of 7 production sites and 2 R&D centers across Europe, employing approximately 1,800 people. The company provides development, manufacturing, quality, regulatory, and logistics services for a wide range of pharmaceutical and consumer care products across 80+ international markets, with capabilities spanning from oral solid dose to sterile injectables and HPAPI products.

Fareva

Brazil

Fareva is a family-owned French CDMO and the largest in France, employing 13,000 people across 41 production sites in 13 countries with EUR 2.22 billion revenue in 2025. The company provides comprehensive pharmaceutical subcontracting from API manufacturing (including HPAPIs, cytotoxics, hormones, steroids, and controlled substances) to finished drug product manufacturing and packaging across oral, sterile injectable, nasal, ophthalmic, and semi-solid dosage forms.

FarmaTek

Turkey

FarmaTek (Farmatek Ilac San ve Tic A.S.) is a Turkish pharmaceutical company founded in 1991 that transitioned from drug importing to manufacturing, incorporating a hybrid business model including CDMO services. The company operates a GMP-approved production facility in Kirklareli Organized Industrial Zone (approved 2017) and received EU GMP certification in 2021.

Fermion, a wholly owned subsidiary of Orion Corporation (Finland), is a CDMO specializing in developing, manufacturing, and marketing small molecule Active Pharmaceutical Ingredients (APIs), including HPAPIs, cytotoxics, steroids, generics, and controlled substances. Together with its parent Orion, it offers integrated contract development and manufacturing services for both drug substances and drug products, covering the full lifecycle from preclinical to commercial scale. FDA-approved since 1979 and EMA-approved since 1971.

Finecure Pharmaceuticals Limited

India

Finecure Pharmaceuticals Limited is an Indian pharmaceutical formulation company with WHO-GMP certified manufacturing facilities producing oral dosage forms and injections. The company focuses on niche therapeutic segments including cardiovascular, anti-retroviral, neurology, and anti-infectives, with a presence across India and export markets.

Fisher Clinical Services (Thermo Fisher)

United States

Fisher Clinical Services, part of Thermo Fisher Scientific, specializes in clinical trial supply chain management including clinical packaging, labeling, storage, and distribution of investigational medicinal products. It operates as the clinical supply arm of Thermo Fisher's broader Accelerator Drug Development platform.

Formulated Solutions

United States

Formulated Solutions is a U.S.-based CDMO providing formulation development, analytical development, manufacturing, regulatory affairs, and packaging services for pharmaceutical and consumer health products. The company offers flexible manufacturing from small-scale clinical batches to large-scale commercial production across multiple dosage forms.

FRIULCHEM S.P.A

Italy

FRIULCHEM S.P.A is an Italian CDMO dedicated primarily to animal health, providing contract development and manufacturing of veterinary pharmaceutical products and complementary feeds. The company operates GMP-authorized facilities in Vivaro, Italy and Magny-en-Vexin, France, offering services including micronization, granulation, mixing, spray drying, and packaging, with patented FC-Cubes chewable tablet technology.

Gaelic Laboratories Limited

Ireland

Gaelic Laboratories Limited is an Irish contract manufacturer specializing in Beta-Lactam (penicillin) products in tablet, capsule, and powder for suspension form. Established in 2022 on a site with 40 years of FDA-approved Beta-Lactam manufacturing history, the company serves EU, UK, and MENA markets. The facility spans 8,000 sqm across two GMP manufacturing plants on an 11-acre site, with HPRA licensing.

GENSENTA

Turkey

Gensenta (formerly Mustafa Nevzat Ilac, acquired by Amgen in 2012 and sold to Eczacibasi in 2020) is a vertically integrated Turkish pharmaceutical company with two manufacturing facilities in Yenibosna and Sekerpinar, Turkey. The company manufactures both drug products and raw materials (APIs), and has been recognized in the sterile injectable CDMO market. Gensenta is listed as part of the Eczacibasi group and produces pharmaceuticals including caspofungin.

Getwell Pharma (India) Pvt Ltd

India

Getwell Pharma (India) Pvt Ltd is an Indian pharmaceutical company and a leading player in the oncology finished dosage formulation segment for more than 3 decades. The company manufactures and supplies anti-cancer drugs from its state-of-the-art manufacturing facility. Getwell holds FDA registration and has a global presence across multiple countries.

GMP Laboratories of America, Inc.

United States

GMP Laboratories of America, Inc. is a US-based CDMO providing contract development and manufacturing services for oral solid dosage forms, liquids, semi-solids, and topical products. The company offers formulation development, analytical testing, stability studies, and commercial-scale manufacturing from its FDA-registered facility. It serves pharmaceutical and dietary supplement markets.

Gofarm Sp. z o.o. Sp.k

Poland

Gofarm Sp. z o.o. Sp.k is a Polish CDMO providing contract development and manufacturing services for pharmaceutical products, dietary supplements, and cosmetics. The company offers formulation development, analytical testing, stability studies, and commercial manufacturing for oral solid dosage forms, liquids, and semi-solid products. It operates from EU GMP-compliant facilities in Poland.

Groupe PARIMA

Canada

Groupe PARIMA is a Canadian CDMO founded in 1994 specializing in the development and manufacturing of non-sterile liquids, suspensions, and semi-solid drug products. Operating from a 67,000 sq ft facility in Montreal, the company provides turnkey services from formulation development through commercial production, supplying drug products to over 30 global markets.

Groupe SYNERLAB CDMO

France

Groupe SYNERLAB (now operating as Meribel Pharma Solutions) is a mid-size European CDMO with an integrated network of manufacturing sites across Europe, providing end-to-end services from API manufacturing through finished dosage forms. The company specializes in sterile multidoses, sterile and non-sterile lyophilized products, sachets, stick packs, oral solid dose, liquids, and semi-solids.

Grünenthal PRO (Grünenthal CDMO)

Chile

Duplicate entry of Grunenthal PRO (company ID 8756785b). Grunenthal PRO is the contract manufacturing arm of Grunenthal Group, operating five specialized plants with vertically integrated manufacturing from active substance to finished products. Approximately 50% of total production is for third-party clients across 100+ countries.

Grupo Azevedos (Sofarimex)

Portugal

Grupo Azevedos, operating through its Sofarimex manufacturing unit, is a Portuguese CDMO specializing in freeze-dried injectables and sterile eye drops, with over 20 years of contract manufacturing experience. The company manufactures pharmaceutical medicines and health products for third parties across non-sterile solid, semi-solid, and liquid forms, as well as sterile products, and holds manufacturing licenses from INFARMED and multiple international authorities.

Grupo Medinfar

Portugal

Grupo Medinfar is a Portuguese pharmaceutical company founded in 1970, with an industrial unit that has provided contract manufacturing services for over 20 years. The company manufactures non-sterile solid, semi-solid, and liquid pharmaceutical products for third-party clients, offering turnkey and custom services including bulk manufacturing, packaging, analytical release, and scale-up support.

Gruppo Farma Impresa S.r.l.

Italy

Gruppo Farma Impresa is an Italian contract manufacturer specializing in medical devices based on substances, food supplements, and dermocosmetics, offering private label production (conto terzi) and out-licensing of over 1,000 ready-to-market products. The company provides formulation development, R&D with over 200 new formulations annually, regulatory affairs support, and clinical trial services across multiple therapeutic areas.

Hubot CDMO | Tri-Pac, Inc.

United States

Hubot CDMO (Tri-Pac, Inc.) is a U.S.-based contract manufacturer providing CDMO solutions for consumer healthcare (medical devices, OTC) and personal care products. The company focuses on aerosol filling, liquid filling, and proprietary dispensing solutions with an emphasis on sustainability and quality.

Huvepharma

Bulgaria

Huvepharma is a fast-growing global pharmaceutical company focused on developing, manufacturing, and marketing human health and animal health and nutrition products. The company masters the complete production cycle in-house from strain to shelf, with a distribution network covering more than 90 countries across 6 continents.

Shenzhen Hybio Pharmaceutical Co., Ltd. (Hybio) is a Chinese pharmaceutical company founded in 1998, specializing in peptide drug R&D, manufacturing, and commercialization with a CRDMO division. The company focuses on peptide APIs (including semaglutide) and sterile injectable formulations, with products sold in 30+ countries. Hybio has 7 FDA-registered facilities and a strategic partnership with Dr. Reddy's for peptide API supply, and recently partnered with Huawei for AI-driven drug development.

ICE Pharma is a niche API and specialty ingredients CDMO founded in 1949 in Italy, focused on the development and manufacture of bile acid derivatives including Ursodeoxycholic Acid (UDCA). The company operates a fully vertically integrated manufacturing network of 7 global production facilities and provides CDMO services for both APIs and finished dosage forms, as well as custom carbohydrate chemistry through its Dextra unit.

IDI Integratori Dietetici Italiani srl is an Italian pharmaceutical company engaged in the development and manufacturing of pharmaceutical products, dietary supplements, and medical devices. The company has FDA-registered facilities and produces a range of products including tablets, creams, oral solutions, and injectable formulations across multiple therapeutic areas.

Ivers‑Lee Group

Switzerland

Ivers-Lee Group is a Swiss family-owned pharmaceutical packaging specialist and CMO with over 75 years of experience, operating from cGMP-approved sites in Burgdorf, Switzerland and Loerrach, Germany. The company packages branded pharmaceutical products for small, medium, and multinational firms and provides clinical trial supply management through its IL-CSM subsidiary. Ivers-Lee was acquired by Alvotech to expand biosimilar assembly and packaging capacity.

JEWIM Pharmaceutical (Shandong) Co., Ltd. is a Chinese pharmaceutical company in transformation, focusing on innovative drugs and complex drug delivery systems including inhalation products, nasal sprays, and long-acting injectable microspheres. The company is an established CDMO/CMO partner for multinational pharma companies including Johnson & Johnson (Xian Janssen), Kenvue, and Bayer, with quality systems certified by US FDA and Australian TGA. Products are exported to over 80 countries.

Jubilant HollisterStier CMO

Canada

Jubilant HollisterStier CMO (subsidiary of Jubilant Pharma) specializes in sterile fill-finish, lyophilization, injectables, ophthalmics, otics, topicals, and liquids for pharmaceutical and biopharmaceutical clients. End-to-end services from process development to inspection and packaging. Facilities in Spokane, WA and Montreal, QC. Won AWB Manufacturer of the Year 2024 and Manufacturing Excellence Award 2025. Largest manufacturer by employees in Spokane area. 92% repeat customer rate. FDA registered with 4 FEI numbers, 28 inspections (6 NAI, 18 VAI, 4 OAI -- elevated regulatory risk).

KLEVA PHARMA (M.J. Kleva SA)

Greece

KLEVA Pharmaceuticals S.A. is a Greek pharmaceutical company established in 1974, specializing in contract manufacturing and technology transfer services. They operate two manufacturing sites in Greece, including a sterile area with filling capability expanded in 2019. KLEVA holds ISO 9001:2015 and EU GMP certification. Their R&D department develops generic pharmaceutical dossiers in CTD format, from patent search and API sourcing through formulation development, pilot-scale batches, stability studies, and dossier compilation. They have 190 marketing authorizations across Europe, Asia, Oceania, and Africa, serving over 50 customers in 30+ countries since 2012.

KLOCKE GRUPPE

Germany

KLOCKE Gruppe is a leading European contract manufacturer and contract packager of pharmaceuticals, medical devices, and nutritional supplements. They operate through two divisions: KLOCKE Pharma-Service (contract manufacturing of granules, tablets, film-coated tablets, dragees, hard capsules, and sachets) and KLOCKE Verpackungs-Service (contract packaging into cold and thermoformed blisters, bottles, and liquid filling). With 750 employees worldwide, over 60 years of family tradition, ~3,000 product items, and ~EUR 140M revenue, they are one of the largest pharmaceutical contract packagers in Europe. FDA-registered (3 FEI numbers) with operations in Germany.

Labialfarma

Portugal

Labialfarma is a Portuguese CDMO established in 1981, specializing in the development and contract manufacturing of nutraceuticals, medicines, cosmetics, medical devices, and complementary feed products. They serve over 15 million people worldwide annually. Their capabilities span solid, semi-solid, and liquid dosage forms, with proprietary technologies including flavoring, sealed benefit protection, rapid disintegration, and SmartPACKAGING innovations. They offer end-to-end services from formulation development to finished product packaging. Labialfarma is primarily focused on the nutraceutical/food supplement space rather than prescription pharmaceuticals.

LABOMAR S.P.A.

Italy

LABOMAR S.p.A. is an Italian CDMO with 25+ years of experience, specializing in the research, development, and contract manufacturing of innovative food supplements, medical devices, foods for special medical purposes, and cosmetics. The company is a portfolio company of Charterhouse Capital Partners. LABOMAR operates as a one-stop-shop CDMO producing solid, liquid, and semi-solid dosage forms. They have expanded internationally through acquisitions including Finnish company Pharmia and Canadian company ImportFab. LABOMAR is a Certified B Corporation and primarily serves the nutraceutical rather than prescription pharmaceutical market.

Laboratorios Salvat, S.A.

Spain

Laboratorios Salvat is a Spanish pharmaceutical company with over 60 years of experience offering CDMO services. Listed on CPHI Online as a contract development and manufacturing organization, the company is recognized in the ophthalmic drugs contract manufacturing market alongside major players like Lonza and Siegfried. Their Pharmaloop facility enhances production capabilities. Primarily focused on sterile ophthalmic and otolaryngology products.

Lavipharm

Greece

Lavipharm is a dynamic, international healthcare company listed on the Athens Stock Exchange since 1995, based in Greece. Their manufacturing plant is one of the few pharmaceutical manufacturing sites in Europe with fully integrated production lines, including dedicated lines for transdermal drug delivery systems (TDDS). The production facility covers 8,000 m2 and produces tablets, capsules, transdermal systems, oral liquids, creams, and ointments under strict GMP conditions. Lavipharm collaborates with FAMAR for contract manufacturing and has launched the first locally produced medical cannabis prescription product in Greece. They also partner with other companies for manufacturing services.